TY - JOUR
T1 - A Critical role for protein kinase C-θ-mediated T cell survival in cardiac allograft rejection
AU - Manicassamy, Santhakumar
AU - Yin, Dengping
AU - Zhang, Zheng
AU - Molinero, Luciana L.
AU - Alegre, Marisa Luisa
AU - Sun, Zuoming
PY - 2008
Y1 - 2008
N2 - Protein kinase C (PKC)-θ mediates the critical TCR signals required for T cell activation. Previously, we have shown that in response to TCR stimulation, PKC-θ-/- T cells undergo apoptosis due to greatly reduced levels of the anti-apoptotic molecule, Bcl-xL. In this study, we demonstrate that PKC-θ-reguIated expression of Bcl-xL is essential for T cell-mediated cardiac allograft rejection. Rag1-/- mice reconstituted with wild-type T cells readily rejected fully mismatched cardiac allografts, whereas Rag1-/- mice reconstituted with PKC-θ-/- T cells failed to promote rejection. Transgenic expression of Bcl-xL in PKC-θ-/- T cells was sufficient to restore cardiac allograft rejection, suggesting that PKC-θ-regulated survival is required for T cell-mediated cardiac allograft rejection in this adoptive transfer model. In contrast to adoptive transfer experiments, intact PKC-θ-/- mice displayed delayed, but successful cardiac allograft rejection, suggesting the potential compensation for PKC-θ function. Finally, a subthera-peutic dose of anti-CD154 Ab or CTLA4-Ig, which was not sufficient to prevent cardiac allograft rejection in the wild-type mice, prevented heart rejection in the PKC-θ-/- mice. Thus, in combination with other treatments, inhibition of PKC-θ may facilitate achieving long-term survival of allografts.
AB - Protein kinase C (PKC)-θ mediates the critical TCR signals required for T cell activation. Previously, we have shown that in response to TCR stimulation, PKC-θ-/- T cells undergo apoptosis due to greatly reduced levels of the anti-apoptotic molecule, Bcl-xL. In this study, we demonstrate that PKC-θ-reguIated expression of Bcl-xL is essential for T cell-mediated cardiac allograft rejection. Rag1-/- mice reconstituted with wild-type T cells readily rejected fully mismatched cardiac allografts, whereas Rag1-/- mice reconstituted with PKC-θ-/- T cells failed to promote rejection. Transgenic expression of Bcl-xL in PKC-θ-/- T cells was sufficient to restore cardiac allograft rejection, suggesting that PKC-θ-regulated survival is required for T cell-mediated cardiac allograft rejection in this adoptive transfer model. In contrast to adoptive transfer experiments, intact PKC-θ-/- mice displayed delayed, but successful cardiac allograft rejection, suggesting the potential compensation for PKC-θ function. Finally, a subthera-peutic dose of anti-CD154 Ab or CTLA4-Ig, which was not sufficient to prevent cardiac allograft rejection in the wild-type mice, prevented heart rejection in the PKC-θ-/- mice. Thus, in combination with other treatments, inhibition of PKC-θ may facilitate achieving long-term survival of allografts.
UR - http://www.scopus.com/inward/record.url?scp=47949130474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47949130474&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.181.1.513
DO - 10.4049/jimmunol.181.1.513
M3 - Article
C2 - 18566417
AN - SCOPUS:47949130474
SN - 0022-1767
VL - 181
SP - 513
EP - 520
JO - Journal of Immunology
JF - Journal of Immunology
IS - 1
ER -